NAYA Biosciences Inc. (NAYA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.39
-0.00 (-1.07%)
At close: Feb 11, 2025, 3:59 PM
0.38
-3.65%
After-hours Feb 11, 2025, 06:59 PM EST
undefined% (undefined)
Bid | 0.37 |
Market Cap | 2.76M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -1.01 |
PE Ratio (ttm) | -0.39 |
Forward PE | n/a |
Analyst | Buy |
Ask | 0.4 |
Volume | 280,173 |
Avg. Volume (20D) | 157,475 |
Open | 0.39 |
Previous Close | 0.39 |
Day's Range | 0.35 - 0.43 |
52-Week Range | 0.35 - 3.50 |
Beta | undefined |
About NAYA
INVO Bioscience is a medical device company providing devices and products for infertility diagnosis. Its flagship product is INVOcell, a reproductive technology that allows fertilization and early embryo development to take place within the woman’s body....
Industry Medical/Nursing Services
Sector Healthcare
IPO Date Nov 2, 2020
Employees 30
Stock Exchange NASDAQ
Ticker Symbol NAYA
Website http://www.nayabiosciences.com
Analyst Forecast
According to 1 analyst ratings, the average rating for NAYA stock is "Buy." The 12-month stock price forecast is $2, which is an increase of 413.87% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
Why Price Moved
4 weeks ago
-38.53%
NAYA Biosciences shares are trading lower after th...
Unlock content with
Pro Subscription
1 month ago
+9.74%
NAYA Biosciences shares are trading higher after the company announced the development of NY-500 novel AI-optimized PD X VEGF bifunctional antibody.